65,437 trials
Autoantibody Positive · Non-diabetic Relatives at Risk for Type 1 Diabetes · High Risk
Primary: Rate of New Diabetes Per Year — 43; 72 N diabetes per 100 participant years
Amputation, Limb Loss
Primary: Short Musculoskeletal Function Assessment (SMFA) — 32.34; 30.19 score on a scale
Hypercholesterolemia · Heterozygous Familial Hypercholesterolemia
Primary: Number of Participants Who Experienced Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and TEAEs Leading to Death — 12; 42; 54; 4 Participants
Cerebral Palsy · Physical Activity · Attention Disorder
Primary: Change of Clinical Global Improvement(CGI) — -0.13; -0.09; 2.65; 3.87 score on a scale
Global Surgery · Medical Missions
Primary: Q7: Country Where the Last Mission Took Place — 2; 2; 1; 1 Participants
Sleep Apnea Syndromes · Sleep Initiation and Maintenance Disorders
Primary: Insomnia Severity Index Score — -8.2; -7.33; -6.27 score on a scale — p=0.8
Smoking Cessation · Opioid Related Disorders
Primary: Recruitment, Assignment to Treatment, and Retention Rates — 40; 33; 15; 32 Participants
Coronary Artery Disease
Primary: Sensitivity and Specificity for Detection or Exclusion of Coronary Artery Disease (CAD) — 8.0; 33.7 percentage of participants — p=0.0896
Coronary Artery Disease
Primary: Sensitivity and Specificity of Lumason Enhanced Dobutamine Stress Echo (DSE) for Detection or Exclusion of Coronary Artery Disease (CAD) — 16.0; 37.9 percentage of…
Healthy
Primary: Change From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation — -0.349 percentage of BOLD signal change — p=<0.0001
Congestive Heart Failure · Sleep Apnea Syndromes
Primary: Number of Participants Adhering to Positive Airway Pressure (PAP) — 5; 3 Participants — p=0.72
Muscular Dystrophy, Duchenne · Muscular Dystrophies · Muscular Disorders, Atrophic
Primary: Change From Baseline in 6MWD at Week 48 — -60.67; -47.69 meters — p=0.213
Actinic Keratosis
Primary: Changes From Baseline in Actinic Keratosis - Lesion Base Count. — 1.15; 2.65; 1.15; 2.60 lesions — p=<0.001
Short Bowel Syndrome
Primary: Change From Baseline in Weekly Parenteral Support (PS) Volume at End of Treatment/Early Termination (EOT/ET) — -2.92 Liter per week (L/Week)
Prostate Cancer
Primary: Change in Satisfaction With Care — 0.26; 0.07; 0.28; 0.06 units on a scale